America Is About to Go Over a Peptide Cliff

Popular gray-market drugs may soon be easy to get through mainstream channels.

FDA panel recommends loosening restrictions on peptides, despite scientists' concerns

The peptides being evaluated have been proposed to treat conditions including insomnia, ulcerative colitis, migraines and ...

The Precision Peptide Company Applauds FDA Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV

On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8-6 (one abstention) to recommend BPC-157 for inclusion on the Section 503A Bulks List.BPC-157 was the first of seven peptides ...
ABC News on MSN

FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list

The vote is non-binding and still needs sign-off from the FDA.